Home > PJ (current issue) > The Society / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7440 p229
24 February 2007


Society summary


Welsh board seeks to strengthen communications

Welsh Pharmacy Board logo

February board meeting

Attendance Present at the meeting were the chairman (Peter Jones), the vice-chairman (Marc Donovan), Alan Crabbe, Jodine Evans, Richard Evans, Diane Heath, Carwyn Jones, Alan Kershaw, Rowena McArtney, Phil Parry, David Temple, Fiona Price and Cath O’Brien (Director for Wales).

Apologies Apologies for absence were received from Mair Davies, Hemant Patel (President of the Society) and Colin Ranshaw (Council member and ex-officio board member).

Guests Present by invitation were Alan Hughes (Clwyd branch), Gemma Inkpen (Cardiff and Vale branch) and Lesley Morgan (member of Council).

Efforts to improve the Royal Pharmaceutical Society's communications in Wales were made at the first meeting of the Society's new Welsh Pharmacy Board, held on 7 February.

The board agreed to establish a Communications and Public Affairs Group, which would be reviewed in January 2008. The group would be chaired by the vice-chairman. Its other members would be the chairman and two board members. Richard Evans and Diane Heath were elected to the places for board members.

Discussing a draft communications and public affairs plan for 2007, the board agreed that a number of comments should be discussed at the first CPAG meeting, on 15 March. A final draft of the plan would then be sent out to the board for ratification.

It was agreed that engagement with patient and voluntary organisations should be strengthened by nominating board members to key organisations to develop stronger links and to promote ongoing working relationships with these bodies.

It was also agreed that board members would attend all four political party conferences in Wales in the spring, as follows: Labour (Llandudno, 22–24 February), Carwyn Jones; Conservative (Cardiff, 3–4 March), Alan Crabbe; Liberal Democrat (Swansea. 9–11 March), Jodine Evans; Plaid Cymru (Caernarfon, 24–26 March), Carwyn Jones.

The board also agree to improve its engagement with the Society’s branches in Wales by aligning one board member with each of the 10 branches. In the first instance, contact would be made by telephone to establish how active each branch was and to obtain a brief verbal report on activities. This would facilitate further discussion by the board.

Election of officers The board began its meeting by adopting the Society’s national boards governance handbook and then electing a chairman and vice-chairman in accordance with procedures set out in the handbook.

In the election of a chairman, Peter Jones was the only candidate. He was nominated by Phil Parry and seconded by Richard Evans. In the election of a vice-chairman, there were two nominations. David Temple was nominated by Rowena McArtney and seconded by Alan Crabbe. Marc Donovan was nominated by Fiona Price and seconded by Diane Heath. After the two candidates had been given an opportunity to explain why they wished to be considered for the position, Mr Donovan was elected by eight votes to three.

Meetings and events The board agreed that no annual meeting of the members in Wales would take place in 2007. Instead, ideas would be developed for an event in spring 2008 that would enable greater participation and involvement for all members in Wales.

The board was advised that the meeting had never been particularly successful, typically attracting only about 40 members, including members of the former Welsh Executive. It was agreed that the CPAG would look in details at ideas for engaging with the members in Wales and would bring proposals back to the board.

The board agreed that the annual meeting for secretaries of branches and pharmacy development groups should continue as planned for 3 May, with a review following the meeting to consider the purpose and structure of future meetings.

It was also agreed to hold a dinner for key stakeholders in Wales in June 2007.

Back to Top


©The Pharmaceutical Journal